These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 10384152)

  • 21. Tumor associated antigens in human renal cell carcinoma: MHC restricted recognition by cytotoxic T lymphocytes.
    Bernhard H; Jäger E; Maeurer MJ; Meyer zum Büschenfelde KH; Knuth A
    Tissue Antigens; 1996 Jul; 48(1):22-31. PubMed ID: 8864171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simultaneous cellular and humoral immune response against mutated p53 in a patient with lung cancer.
    Ichiki Y; Takenoyama M; Mizukami M; So T; Sugaya M; Yasuda M; So T; Hanagiri T; Sugio K; Yasumoto K
    J Immunol; 2004 Apr; 172(8):4844-50. PubMed ID: 15067062
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor-Infiltrating T Cells From Clear Cell Renal Cell Carcinoma Patients Recognize Neoepitopes Derived From Point and Frameshift Mutations.
    Hansen UK; Ramskov S; Bjerregaard AM; Borch A; Andersen R; Draghi A; Donia M; Bentzen AK; Marquard AM; Szallasi Z; Eklund AC; Svane IM; Hadrup SR
    Front Immunol; 2020; 11():373. PubMed ID: 32226429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Utilization of an alternative open reading frame of a normal gene in generating a novel human cancer antigen.
    Wang RF; Parkhurst MR; Kawakami Y; Robbins PF; Rosenberg SA
    J Exp Med; 1996 Mar; 183(3):1131-40. PubMed ID: 8642255
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human renal cell carcinoma antigen-specific CTLs: antigen-driven selection and long-term persistence in vivo.
    Jantzer P; Schendel DJ
    Cancer Res; 1998 Jul; 58(14):3078-86. PubMed ID: 9679974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An additional ORF on meloe cDNA encodes a new melanoma antigen, MELOE-2, recognized by melanoma-specific T cells in the HLA-A2 context.
    Godet Y; Moreau-Aubry A; Mompelat D; Vignard V; Khammari A; Dreno B; Lang F; Jotereau F; Labarriere N
    Cancer Immunol Immunother; 2010 Mar; 59(3):431-9. PubMed ID: 19730858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A ras-mutated peptide targeted by CTL infiltrating a human melanoma lesion.
    Linard B; Bézieau S; Benlalam H; Labarrière N; Guilloux Y; Diez E; Jotereau F
    J Immunol; 2002 May; 168(9):4802-8. PubMed ID: 11971032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of new melanoma epitopes on melanosomal proteins recognized by tumor infiltrating T lymphocytes restricted by HLA-A1, -A2, and -A3 alleles.
    Kawakami Y; Robbins PF; Wang X; Tupesis JP; Parkhurst MR; Kang X; Sakaguchi K; Appella E; Rosenberg SA
    J Immunol; 1998 Dec; 161(12):6985-92. PubMed ID: 9862734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Killer inhibitory receptor (CD158b) modulates the lytic activity of tumor-specific T lymphocytes infiltrating renal cell carcinomas.
    Guerra N; Guillard M; Angevin E; Echchakir H; Escudier B; Moretta A; Chouaib S; Caignard A
    Blood; 2000 May; 95(9):2883-9. PubMed ID: 10779435
    [TBL] [Abstract][Full Text] [Related]  

  • 30. C19orf48 encodes a minor histocompatibility antigen recognized by CD8+ cytotoxic T cells from renal cell carcinoma patients.
    Tykodi SS; Fujii N; Vigneron N; Lu SM; Mito JK; Miranda MX; Chou J; Voong LN; Thompson JA; Sandmaier BM; Cresswell P; Van den Eynde B; Riddell SR; Warren EH
    Clin Cancer Res; 2008 Aug; 14(16):5260-9. PubMed ID: 18698046
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased expression of activation markers in renal cell carcinoma infiltrating lymphocytes.
    Shabtai M; Ye H; Frischer Z; Martin J; Waltzer WC; Malinowski K
    J Urol; 2002 Nov; 168(5):2216-9. PubMed ID: 12394762
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of an in vitro immunoselected tumor line to identify shared melanoma antigens recognized by HLA-A*0201-restricted T cells.
    Harada M; Li YF; El-Gamil M; Rosenberg SA; Robbins PF
    Cancer Res; 2001 Feb; 61(3):1089-94. PubMed ID: 11221837
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of five MAGE-A1 epitopes recognized by cytolytic T lymphocytes obtained by in vitro stimulation with dendritic cells transduced with MAGE-A1.
    Chaux P; Luiten R; Demotte N; Vantomme V; Stroobant V; Traversari C; Russo V; Schultz E; Cornelis GR; Boon T; van der Bruggen P
    J Immunol; 1999 Sep; 163(5):2928-36. PubMed ID: 10453041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A mutated beta-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes.
    Robbins PF; El-Gamil M; Li YF; Kawakami Y; Loftus D; Appella E; Rosenberg SA
    J Exp Med; 1996 Mar; 183(3):1185-92. PubMed ID: 8642260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence for oligoclonal T-cell response in a metastasis of renal cell carcinoma responding to vaccination with autologous tumor cells and transfer of in vitro-sensitized vaccine-draining lymph node lymphocytes.
    Weidmann E; Logan TF; Yasumura S; Kirkwood JM; Trucco M; Whiteside TL
    Cancer Res; 1993 Oct; 53(20):4745-9. PubMed ID: 8402652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High efficiency TCR gene transfer into primary human lymphocytes affords avid recognition of melanoma tumor antigen glycoprotein 100 and does not alter the recognition of autologous melanoma antigens.
    Morgan RA; Dudley ME; Yu YY; Zheng Z; Robbins PF; Theoret MR; Wunderlich JR; Hughes MS; Restifo NP; Rosenberg SA
    J Immunol; 2003 Sep; 171(6):3287-95. PubMed ID: 12960359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of T-cell immune response in renal cell carcinoma: polarization to type 1-like differentiation pattern, clonal T-cell expansion and tumor-specific cytotoxicity.
    Angevin E; Kremer F; Gaudin C; Hercend T; Triebel F
    Int J Cancer; 1997 Jul; 72(3):431-40. PubMed ID: 9247286
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor-infiltrating T lymphocytes from renal-cell carcinoma express B7-1 (CD80): T-cell expansion by T-T cell co-stimulation.
    Thurnher M; Radmayr C; Hobisch A; Böck G; Romani N; Bartsch G; Klocker H
    Int J Cancer; 1995 Sep; 62(5):559-64. PubMed ID: 7545143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of naturally processed and HLA-A1-presented melanoma T-cell epitopes defined by CD8(+) T-cells' release of granulocyte-macrophage colony-stimulating factor but not by cytolysis.
    Maeurer MJ; Martin D; Elder E; Storkus WJ; Lotze MT
    Clin Cancer Res; 1996 Jan; 2(1):87-95. PubMed ID: 9816095
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficient identification of mutated cancer antigens recognized by T cells associated with durable tumor regressions.
    Lu YC; Yao X; Crystal JS; Li YF; El-Gamil M; Gross C; Davis L; Dudley ME; Yang JC; Samuels Y; Rosenberg SA; Robbins PF
    Clin Cancer Res; 2014 Jul; 20(13):3401-10. PubMed ID: 24987109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.